OncoMed Pharmaceuticals Inc
-
OncoMed’s experimental lung cancer drug failed a mid-stage study
Apr 17, 2017News Hour: OncoMed Pharmaceuticals Inc said on Monday its experimental lung cancer drug failed a mid-stage study, sending its shares tumbling 30 percent in premarket trading. This is the second major setback for OncoMed this month...